Hyasynth Biologicals Inc.
PrivateLast Round
Convertible Debt
Dec 22, 2021
Total Funding Raised
$10.05M
Company Overview
Hyasynth Biologicals Inc. operates in Healthcare & Life Sciences and is based in Montreal. Its latest recorded funding round was a Convertible Debt round in December 2021.
Hyasynth Biologicals Inc. is a biotechnology company that produces pure, sustainable cannabinoid ingredients through precision fermentation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hyasynth Biologicals Inc. Comparables
Compare Hyasynth Biologicals Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biomedican | 93% | |
| Purissima | 87% | |
| Creo | 86% |
For institutional investors. Book with your work email.
Hyasynth Biologicals Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Dec 22, 2021 | ||||
| Convertible Debt | Oct 23, 2020 | ||||
| Convertible Debt | Sep 13, 2018 | ||||
| Seed | Nov 30, 2017 | ||||
| Accelerator | Nov 12, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Hyasynth Biologicals Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IndieBio | Accelerator |
| Anges Quebec | Seed |
| MassChallenge Israel | Seed |
| SOSV | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors increased 79% MoM.
- May 1, 2025
Monthly visitors grew 156% MoM.
For institutional investors. Book with your work email.
Hyasynth Biologicals Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hyasynth Biologicals Inc.'s valuation, stock price, and market status.
Is Hyasynth Biologicals Inc. a public or private company?
Hyasynth Biologicals Inc. is a private company.
What is the current stock price of Hyasynth Biologicals Inc.?
Hyasynth Biologicals Inc. is a private company, so its shares have no public market price. Caplight tracks Hyasynth Biologicals Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hyasynth Biologicals Inc. worth (valuation)?
Valuation information for Hyasynth Biologicals Inc. is not publicly available.
Can I buy Hyasynth Biologicals Inc. stock?
Hyasynth Biologicals Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hyasynth Biologicals Inc.'s last funding round?
Hyasynth Biologicals Inc.'s most recent funding round was Convertible Debt on December 22, 2021.
Who are the main investors in Hyasynth Biologicals Inc.?
Key investors in Hyasynth Biologicals Inc. include IndieBio, Anges Quebec, MassChallenge Israel, SOSV.
Will Hyasynth Biologicals Inc. IPO soon?
No public IPO plans have been announced for Hyasynth Biologicals Inc..
How can I track Hyasynth Biologicals Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Hyasynth Biologicals Inc.'s shares on secondary markets.